(Tyr0)-Melanocyte-Stimulating Hormone-Release Inhibiting Factor is a modified neuropeptide with a tyrosine substitution at the N-terminus, enhancing its binding profile and stability. The additional aromatic group increases the peptide's interaction with melanocortin receptors, modulating hormone release. Researchers use it to investigate the inhibition of melanocyte-stimulating hormone release and its role in skin pigmentation.
CAT No: M2803
CAS No:77133-61-0
Synonyms/Alias:(Tyr0)-Melanocyte-Stimulating Hormone-Release Inhibiting Factor;77133-61-0;Glycinamide,L-tyrosyl-L-prolyl-L-leucyl-;SMR000058780;MLS000069590;(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;L-TYROSYL-L-PROLYL-L-LEUCYL-GLYCINAMIDE;Opera_ID_435;MLS001077334;SCHEMBL1372352;CHEMBL1390115;HMS2236N07;(S)-N-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More